Non-Alcoholic Steatohepatitis (NASH) Liver Disease Drug Development Solutions

Meeting today’s unmet needs in NASH (Non-Alcoholic Steatohepatitis) treatment requires more than an ideal drug candidate to reach the market. Accelerating your NASH program demands specialized support that encompasses several key success factors:

• 形成战略临床发展计划
• Designing a customized protocol
• Finding specialized sites to work with liver biopsy, imaging and biomarker needs

Let Covance help you execute a comprehensive strategy that addresses the unique challenges of NASH and meets your requirements—at every stage of development.

Don’t let site selection and patient recruitment challenges hamper your progress. We can keep your NASH drug development timeline on track through site-specific recruitment plans, drawing on our strong network of referral network, key opinion leaders and patient advocacy groups.

With our proprietaryXcellate.^®信息学Platform, including the industry’s largest clinical knowledgebase and outreach across more than 600 global sites across 26 countries, we’ll help you find the right locations for your trial to reach your rapid study start-up goals and employ ongoing initiatives that proactively manage patient retention.

NASH holds many uncertainties in its diagnosis, evaluation, management and progression, but one thing is certain: a dedicated partner with relevant NASH experience can increase your chance of tackling this disease.

依靠我们2型糖尿病，肥胖和脂质的试验的全球历史，以及肝活组织检查，新的生物标志物，成像方法和结果试验的裁决以及在您的计划中提供有价值的见解。我们可以共同努力为您的纳什学习创造新的可能性，并为更加周到，高效的发展造成一条路径。

NASH represents a rapidly developing field with several potential therapeutic options in the pipeline and many more on the horizon, yet none have made it to market. At Covance, we recognized this opportunity to harness our regulatory, medical, scientific and operational expertise and transform results in the field.

我们的投资从积极参与纳什科学界，肝脏论坛和其他与糖尿病相关的专业协会开始了解赞助商的需求。我们已准备好满足您的近期纳什目标，作为持续承诺改变前景的一部分，并对赞助商和患者产生差异。

监管机构支持努力加快纳什这样解决未满足医疗需求的药物的发展。通过许多不同的方法来减少您的产品到营销批准的时间，依靠我们的专业知识来帮助您选择并融入最佳的策略。

We work with NASH experts to shepherd indications and advise submissions to meet global, regional and local approvals. Building off our foundation of strategic preclinical and clinical trial methodologies, we can fully support your approval process—and create the maximum value for your novel NASH product.

As a global CRO that supports novel development with hundreds of sponsors each year, we know how to advance compounds to the clinic and the market. NASH development relies on proven processes, along with additional strategies to:

• Apply adaptive trial designs to improve study efficiency and advance your program
• Incorporate specialized operational experience with novel imaging methods and coordinated interpretation of liver biopsies
• 识别和管理基于风险的监测的风险
• 满足快速研究初创次的时间表并保留患者
• Support global testing and biomarker development
• 利用高级信息学工具并采用电子数据收集表格

With our medical and regulatory team solely devoted to NASH, deep scientific experience and key operational solutions to overcome development hurdles, we’ll help you make an impact in this competitive landscape.

We know NASH and what it takes to get ahead. Now, get to know us to discuss how we can reveal new opportunities for your critical studies.

如果您对其中一个纳什专家有问题，请单击下面的按钮。